-transparent.png){kind=logo}
The pharmacodynamics and pharmacokinetics of hirudin were studied in dogs, rabbits and rats. Hirudin proved to be a well tolerated substance with low toxicity. After intravenous injection it was eliminated with a half time of 50 to 60 min. It was nearly completely excreted through the kidneys in biologically active form. The efficacy of hirudin in preventing venous thrombosis, vascular shunt occlusion and disseminated intravascular coagulation in rats was demonstrated.
Related Publications
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
April 1991,
Thrombosis and haemostasis,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
August 1991,
Thrombosis and haemostasis,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
June 1989,
Thrombosis research,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
July 1963,
Der Urologe,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
January 1991,
Haemostasis,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
December 1988,
Thrombosis research,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
October 1963,
Zeitschrift fur Kreislaufforschung,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
July 1962,
Yao xue xue bao = Acta pharmaceutica Sinica,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
April 1986,
Thrombosis and haemostasis,
F Markwardt, and
J Hauptmann, and
G Nowak, and
C Klessen, and
P Walsmann
February 1990,
Thrombosis and haemostasis,
